Cargando…
Recurrent Clostridium difficile Infection: Risk Factors, Treatment, and Prevention
The most common cause of antibiotic-associated diarrhea is Clostridium difficile infection (CDI). Recurrent C. difficile infection (rCDI) often occurs after successful treatment of CDI. Due to the increased incidence and the difficulty in treating rCDI, it is becoming an important clinical issue. Id...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial Office of Gut and Liver
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6346998/ https://www.ncbi.nlm.nih.gov/pubmed/30400734 http://dx.doi.org/10.5009/gnl18071 |
_version_ | 1783389867600773120 |
---|---|
author | Song, Jung Hoon Kim, You Sun |
author_facet | Song, Jung Hoon Kim, You Sun |
author_sort | Song, Jung Hoon |
collection | PubMed |
description | The most common cause of antibiotic-associated diarrhea is Clostridium difficile infection (CDI). Recurrent C. difficile infection (rCDI) often occurs after successful treatment of CDI. Due to the increased incidence and the difficulty in treating rCDI, it is becoming an important clinical issue. Identifying risk factors is helpful for early detection, treatment, and prevention of rCDI. Advanced age, use of antibiotics, gastric acid suppression, and infection with a hypervirulent strain are currently regarded as the major risk factors for rCDI. Several treatment modalities, including vancomycin, fidaxomicin, and fecal microbiota transplant (FMT), are suggested for rCDI treatment. However, there is currently no definitive treatment method with sufficient evidence for rCDI. Recent studies have focused on FMT and have shown positive results for rCDI. Prevention of rCDI by measures such as hand washing and isolation of patients is very important. However, these preventive measures are often overlooked in clinical practice. Here, we review the risk factors, treatment, and prevention of rCDI. |
format | Online Article Text |
id | pubmed-6346998 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Editorial Office of Gut and Liver |
record_format | MEDLINE/PubMed |
spelling | pubmed-63469982019-02-04 Recurrent Clostridium difficile Infection: Risk Factors, Treatment, and Prevention Song, Jung Hoon Kim, You Sun Gut Liver Review The most common cause of antibiotic-associated diarrhea is Clostridium difficile infection (CDI). Recurrent C. difficile infection (rCDI) often occurs after successful treatment of CDI. Due to the increased incidence and the difficulty in treating rCDI, it is becoming an important clinical issue. Identifying risk factors is helpful for early detection, treatment, and prevention of rCDI. Advanced age, use of antibiotics, gastric acid suppression, and infection with a hypervirulent strain are currently regarded as the major risk factors for rCDI. Several treatment modalities, including vancomycin, fidaxomicin, and fecal microbiota transplant (FMT), are suggested for rCDI treatment. However, there is currently no definitive treatment method with sufficient evidence for rCDI. Recent studies have focused on FMT and have shown positive results for rCDI. Prevention of rCDI by measures such as hand washing and isolation of patients is very important. However, these preventive measures are often overlooked in clinical practice. Here, we review the risk factors, treatment, and prevention of rCDI. Editorial Office of Gut and Liver 2019-01 2018-10-30 /pmc/articles/PMC6346998/ /pubmed/30400734 http://dx.doi.org/10.5009/gnl18071 Text en Copyright © 2019 by The Korean Society of Gastroenterology, the Korean Society of Gastrointestinal Endoscopy, the Korean Society of Neurogastroenterology and Motility, Korean College of Helicobacter and Upper Gastrointestinal Research, Korean Association the Study of Intestinal Diseases, the Korean Association for the Study of the Liver, Korean Pancreatobiliary Association, and Korean Society of Gastrointestinal Cancer. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Song, Jung Hoon Kim, You Sun Recurrent Clostridium difficile Infection: Risk Factors, Treatment, and Prevention |
title | Recurrent Clostridium difficile Infection: Risk Factors, Treatment, and Prevention |
title_full | Recurrent Clostridium difficile Infection: Risk Factors, Treatment, and Prevention |
title_fullStr | Recurrent Clostridium difficile Infection: Risk Factors, Treatment, and Prevention |
title_full_unstemmed | Recurrent Clostridium difficile Infection: Risk Factors, Treatment, and Prevention |
title_short | Recurrent Clostridium difficile Infection: Risk Factors, Treatment, and Prevention |
title_sort | recurrent clostridium difficile infection: risk factors, treatment, and prevention |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6346998/ https://www.ncbi.nlm.nih.gov/pubmed/30400734 http://dx.doi.org/10.5009/gnl18071 |
work_keys_str_mv | AT songjunghoon recurrentclostridiumdifficileinfectionriskfactorstreatmentandprevention AT kimyousun recurrentclostridiumdifficileinfectionriskfactorstreatmentandprevention |